Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-778,875 in dyslipidemia and type 2 diabetes mellitus
NCT00326326Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2006
- Countries
- 1
01
Overview
A Phase 2 trial of cp-778875 in dyslipidemia, sponsored by Pfizer. Started Jul 2006; status: completed.
02
Drugs
cp-778875
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00326326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326326.